...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: A few thoughts on Soliris(Eculizumab) vs. RVX-208 for Compliment-related disease

"SP reached 29 before Phase 1." ,,,,,,,,,,,,,,,back in the hay day of the $29 share price on RVX we only had about 40M shares outstanding,,,,,,,,,,,,so interpolate from that for speculation in todays numbers,,,,,,,,,,,,possibly 35% of the $29 would be appropriate,,,,,just a thought.........seems reasonable,,,,,,,,,,,,,,, $10,,,,,,,,,,,,,,since then days however our target market or markets has changed substantially...........and for the better imo............

Share
New Message
Please login to post a reply